Skip navigation
Home
Menu
Menu
Study
Student life
Research and innovation
Global
About us
Staff
Students
Search the site
Centre of Excellence for Long-acting Therapeutics
Menu
About us
LONGEVITY
HALo
Nanotherapeutics Hub
Teoreler
PKRxiv
LAPaL
Blog
News
Events
Contact us
News
Behavioural Providers Turn to Long-acting Injectables to Boost Adherence, Decrease Burden
05 July 2024
New mRNA technology turns cells into long-lasting drug factories
05 July 2024
Landmark Trial in South Africa and Uganda Finds Twice Yearly HIV Prevention Injection Safe and Highly Effective
28 June 2024
Tirzepatide Shows Efficacy Resolving Metabolic Dysfunction-Associated Steatohepatitis without Worsening of Fibrosis
14 June 2024
Namibian first ladies call for new HIV medicine
14 June 2024
South Africa's roll-out of HIV prevention jabs stymied by price
14 June 2024
U.S. clinical trials begin for twice-yearly HIV prevention injection
10 June 2024
New data provide schizophrenia treatment insights into switching to UZEDY® extended-release injectable suspension from invega sustenna®
10 June 2024
SUPERNOVA Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19 in immunocompromised patient population
17 May 2024
Newer stories
Older Stories